Anna Z. Mykytyn

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster sera.

Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster sera.

Journal: NPJ vaccines

Published: December 12, 2025

Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.

Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.

Journal: The Journal of infection

Published: November 20, 2025

Assessment of SARS-CoV-2 immune escape using antigenic cartography combined with experimental challenge studies.

Assessment of SARS-CoV-2 immune escape using antigenic cartography combined with experimental challenge studies.

Journal: NPJ vaccines

Published: July 14, 2025

Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults.

Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults.

Journal: Nature communications

Published: May 09, 2025

Variable DPP4 expression in multiciliated cells of the human nasal epithelium as a determinant for MERS-CoV tropism.

Variable DPP4 expression in multiciliated cells of the human nasal epithelium as a determinant for MERS-CoV tropism.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 06, 2025

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories.

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories.

Journal: Viruses

Published: November 12, 2024

Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expression.

Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expression.

Journal: Npj viruses

Published: June 05, 2024

Acanthamoeba castellanii trophozoites need oxygen for normal functioning and lipids are their preferred substrate, offering new possibilities for treatment.

Acanthamoeba castellanii trophozoites need oxygen for normal functioning and lipids are their preferred substrate, offering new possibilities for treatment.

Journal: International journal for parasitology

Published: June 05, 2024

Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.

Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.

Journal: Science translational medicine

Published: May 15, 2024

Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial.

Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial.

Journal: The Lancet. Infectious diseases

Published: May 08, 2024

Human metapneumovirus infection of organoid-derived human bronchial epithelium represents cell tropism and cytopathology as observed in in vivo models.

Human metapneumovirus infection of organoid-derived human bronchial epithelium represents cell tropism and cytopathology as observed in in vivo models.

Journal: mSphere

Published: January 24, 2024

Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.

Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.

Journal: NPJ vaccines

Published: January 22, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026